FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055933527> ?p ?o ?g. }

• W2055933527 endingPage "264" @default.
• W2055933527 startingPage "258" @default.
• W2055933527 abstract "Our purpose was to compare the effect of triamcinolone and bevacizumab (Avastin) on the retinal thickness and functional outcome in patients with diabetic macular edema.A collective of 32 patients, who had been treated by a single 4.0-mg intravitreal triamcinolone injection (group 1), was matched to 32 patients ('matched pairs'), who had received 3 injections of 1.25 mg of bevacizumab within 3 months in 4-week intervals (group 2). The outcome variables were changes in best corrected visual acuity (VA) and central retinal thickness 3 months after therapy.Both groups did not differ regarding preoperative VA and central retinal thickness measured by optical coherence tomography. The baseline mean VA was 0.72 +/- 0.39 logMAR in group 1 and 0.73 +/- 0.39 logMAR in group 2 (p = 0.709). The mean central retinal thickness measured by optical coherence tomography was 548 +/- 185 mum in group 1 and 507 +/- 192 mum in group 2. While the patients in group 1 experienced a slight increase in VA of on average 0.7 lines following a single triamcinolone injection to a mean of 0.64 +/- 0.40 logMAR (p = 0.066) after 3 months, the patients in group 2 showed almost no effect on VA with an average increase of 0.2 lines to a mean VA of 0.72 +/- 0.30 logMAR (p = 0.948) following 3 intravitreal injections of bevacizumab. Comparing the effect on VA between both groups no statistically significant difference (p = 0.115) was noted. Concerning decrease in central retinal thickness both therapies were highly effective (p < 0.001 each), again, without statistically significant difference between the groups (p < 0.128).Our data suggest that a single triamcinolone injection may be as effective as a 3 times repeated intravitreal administration of bevacizumab for the treatment of diabetic macular edema. Further prospective trials should be performed." @default.
• W2055933527 created "2016-06-24" @default.
• W2055933527 creator A5007253052 @default.
• W2055933527 creator A5036493614 @default.
• W2055933527 creator A5037807436 @default.
• W2055933527 creator A5046525683 @default.
• W2055933527 creator A5068800257 @default.
• W2055933527 creator A5075076772 @default.
• W2055933527 creator A5082476971 @default.
• W2055933527 date "2010-01-01" @default.
• W2055933527 modified "2023-10-01" @default.
• W2055933527 title "Comparison of Intravitreal Bevacizumab versus Triamcinolone for the Treatment of Diffuse Diabetic Macular Edema" @default.
• W2055933527 cites W1526282761 @default.
• W2055933527 cites W1557788262 @default.
• W2055933527 cites W1559170621 @default.
• W2055933527 cites W1977210385 @default.
• W2055933527 cites W1977305573 @default.
• W2055933527 cites W1980481418 @default.
• W2055933527 cites W1980739597 @default.
• W2055933527 cites W1994047242 @default.
• W2055933527 cites W1995216352 @default.
• W2055933527 cites W1996418653 @default.
• W2055933527 cites W1999718395 @default.
• W2055933527 cites W2011046688 @default.
• W2055933527 cites W2029569083 @default.
• W2055933527 cites W2032711019 @default.
• W2055933527 cites W2033245558 @default.
• W2055933527 cites W2040983439 @default.
• W2055933527 cites W2043162778 @default.
• W2055933527 cites W2055385676 @default.
• W2055933527 cites W2055975267 @default.
• W2055933527 cites W2071223877 @default.
• W2055933527 cites W2071905478 @default.
• W2055933527 cites W2079217070 @default.
• W2055933527 cites W2081633887 @default.
• W2055933527 cites W2082208163 @default.
• W2055933527 cites W2120276758 @default.
• W2055933527 cites W2129375983 @default.
• W2055933527 cites W2137893922 @default.
• W2055933527 cites W2151129590 @default.
• W2055933527 cites W2159536763 @default.
• W2055933527 cites W2337424013 @default.
• W2055933527 cites W2396222049 @default.
• W2055933527 cites W2805868637 @default.
• W2055933527 doi "https://doi.org/10.1159/000284466" @default.
• W2055933527 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20160463" @default.
• W2055933527 hasPublicationYear "2010" @default.
• W2055933527 type Work @default.
• W2055933527 sameAs 2055933527 @default.
• W2055933527 citedByCount "21" @default.
• W2055933527 countsByYear W20559335272012 @default.
• W2055933527 countsByYear W20559335272013 @default.
• W2055933527 countsByYear W20559335272014 @default.
• W2055933527 countsByYear W20559335272015 @default.
• W2055933527 countsByYear W20559335272016 @default.
• W2055933527 countsByYear W20559335272019 @default.
• W2055933527 countsByYear W20559335272020 @default.
• W2055933527 countsByYear W20559335272021 @default.
• W2055933527 countsByYear W20559335272023 @default.
• W2055933527 crossrefType "journal-article" @default.
• W2055933527 hasAuthorship W2055933527A5007253052 @default.
• W2055933527 hasAuthorship W2055933527A5036493614 @default.
• W2055933527 hasAuthorship W2055933527A5037807436 @default.
• W2055933527 hasAuthorship W2055933527A5046525683 @default.
• W2055933527 hasAuthorship W2055933527A5068800257 @default.
• W2055933527 hasAuthorship W2055933527A5075076772 @default.
• W2055933527 hasAuthorship W2055933527A5082476971 @default.
• W2055933527 hasBestOaLocation W20559335272 @default.
• W2055933527 hasConcept C118487528 @default.
• W2055933527 hasConcept C134018914 @default.
• W2055933527 hasConcept C141071460 @default.
• W2055933527 hasConcept C2776694085 @default.
• W2055933527 hasConcept C2777802072 @default.
• W2055933527 hasConcept C2778257484 @default.
• W2055933527 hasConcept C2778818243 @default.
• W2055933527 hasConcept C2778903070 @default.
• W2055933527 hasConcept C2779829184 @default.
• W2055933527 hasConcept C2780347916 @default.
• W2055933527 hasConcept C2780827179 @default.
• W2055933527 hasConcept C2985127711 @default.
• W2055933527 hasConcept C555293320 @default.
• W2055933527 hasConcept C71924100 @default.
• W2055933527 hasConceptScore W2055933527C118487528 @default.
• W2055933527 hasConceptScore W2055933527C134018914 @default.
• W2055933527 hasConceptScore W2055933527C141071460 @default.
• W2055933527 hasConceptScore W2055933527C2776694085 @default.
• W2055933527 hasConceptScore W2055933527C2777802072 @default.
• W2055933527 hasConceptScore W2055933527C2778257484 @default.
• W2055933527 hasConceptScore W2055933527C2778818243 @default.
• W2055933527 hasConceptScore W2055933527C2778903070 @default.
• W2055933527 hasConceptScore W2055933527C2779829184 @default.
• W2055933527 hasConceptScore W2055933527C2780347916 @default.
• W2055933527 hasConceptScore W2055933527C2780827179 @default.
• W2055933527 hasConceptScore W2055933527C2985127711 @default.
• W2055933527 hasConceptScore W2055933527C555293320 @default.
• W2055933527 hasConceptScore W2055933527C71924100 @default.
• W2055933527 hasIssue "4" @default.
• W2055933527 hasLocation W20559335271 @default.

• next